NanoViricides, Inc.
NNVC
$1.26
$0.010.80%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 902.70K | 1.23M | 1.21M | 693.70K | 610.90K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.06M | 3.17M | 2.39M | 1.91M | 2.18M |
| Operating Income | -2.06M | -3.17M | -2.39M | -1.91M | -2.18M |
| Income Before Tax | -2.03M | -3.13M | -2.36M | -1.85M | -2.11M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.03M | -3.13M | -2.36M | -1.85M | -2.11M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.03M | -3.13M | -2.36M | -1.85M | -2.11M |
| EBIT | -2.06M | -3.17M | -2.39M | -1.91M | -2.18M |
| EBITDA | -1.86M | -2.97M | -2.20M | -1.72M | -2.00M |
| EPS Basic | -0.14 | -0.23 | -0.19 | -0.16 | -0.18 |
| Normalized Basic EPS | -0.09 | -0.14 | -0.12 | -0.10 | -0.11 |
| EPS Diluted | -0.14 | -0.23 | -0.19 | -0.16 | -0.18 |
| Normalized Diluted EPS | -0.09 | -0.14 | -0.12 | -0.10 | -0.11 |
| Average Basic Shares Outstanding | 14.57M | 13.72M | 12.24M | 11.78M | 11.75M |
| Average Diluted Shares Outstanding | 14.57M | 13.72M | 12.24M | 11.78M | 11.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |